Increased uric acid promotes decline of the renal function in hypertensive patients: A 10-year observational study

Internal Medicine

Volumn 52, Issue 13, 2013, Pages 1467-1472

  Ohta, Yuko ^a,b   Tsuchihashi, Takuya ^b   Kiyohara, Kanako ^b   Oniki, Hideyuki ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

24 hour urine; Hypertensive patients; Renal function; Uric acid; Uric acid clearance

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CORRELATION ANALYSIS; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY CLEARANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; SODIUM URINE LEVEL; SPHYGMOMANOMETER; URIC ACID URINE LEVEL; URINALYSIS;

AGED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; URIC ACID;

EID: 84879663697     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.0141     Document Type: Article

References (31)

1. Krishnan E, Kwoh K, Schumacher R, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 49: 298-303, 2007.
2. Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Breteler MMB. Uric acid is a risk factor for myocardial infarction and stroke. Rotterdam study. Stroke 37: 1503-1507, 2006.
3. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic sundrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 25: 1038-1044, 2005.
4. Hjortnaes J, Algra A, Olijhoek J, et al. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. J Rheumatol 34: 1882-1887, 2007.
5. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190, 2003.
6. Kawai T, Ohishi M, Onishi M, et al. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 35: 1087-1092, 2012.
7. Ohta Y, Tsuchihashi T, Onaka U, Hasegawa E. Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients. Intern Med 49: 1483-1487, 2010.
8. Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 25: 43-49, 2005.
9. Yu MA, Sánchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the rennin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 28: 1234-1242, 2010.
10. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282: F991-F997, 2002.
11. Sánchez-Lozada LG, Tapia E, Avila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283: F1105-F1110, 2002.
12. Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A. Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif 30: 288-295, 2010.
13. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38: 1101-1106, 2001.
14. Tochikubo O, Uneda S, Kaneko Y. Simple portable device for sampling a whole day's urine and its application to hypertensive outpatients. Hypertension 5: 270-274, 1983.
15. Matsuo S, Imai E, Horio M, et al; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.
16. Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD. The visceral adiposity syndrome in Japanese-American men. Obes Res 2: 364-371, 1994.
17. Park HS, Sim SJ, Park JY. Effect of weight reduction on metabolic syndrome in Korean obese patients. J Korean Med Sci 19: 202-208, 2004.
18. Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 10: 255-264, 1986.
19. Talaat KM, El-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol 27: 435-440, 2007.
20. Sonoda H, Takase H, Dohi Y, Kimura G. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol 33: 352-357, 2011.
21. Miao Y, Ottenbros SA, Laverman GD, et al. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulindependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial. Hypertension 58: 2-7, 2011.
22. Weiner DE, Tighiouaart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19: 1204-1211, 2008.
23. Obermayr RP, Temml C, Gutjahr G, Knechtelsdoefer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19: 2407-2413, 2008.
24. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44: 642-650, 2004.
25. Ito S, Naritomi H, Ogihara T, et al. Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res 35: 867-873, 2012.
26. Kang DH, Nakawawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002.
27. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16: 3553-3562, 2005.
28. Kanbay M, Ozkara A, Selcoki Y, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol 39: 1227-1233, 2007.
29. Goicoechaea M, Vinuesa SG, Verdalles U, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5: 1388-1393, 2010.
30. Committee for the preparation of guidelines for the management of hyperuricemia and gout, Japanese Society of Gout and Nucleic acid Metabolism: guidelines for the management of hyperuricemia and gout. Tokyo, Japanese Society of Gout and Nucleic acid Metabolism, Tokyo, 2010.
31. Yamamoto Y, Matsubara K, Igawa G, et al. Status of uric acid management in hypertensive subjects. Hypertens Res 30: 549-554, 2007.